secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001104659-23-024997
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anzu SPAC enters extension support agreements to push deadline to Sept 30, 2023; target Envoy Medical
--------------------------------------------------------------------------------

- Entered Extension Support Agreements with unaffiliated holders to extend business combination deadline from March 4 to Sept 30, 2023.
- Sponsor to transfer up to 80,000 Founder Shares per holder for each 100,000 Public Shares retained post-extension.
- Holders agreed to vote 3,311,894 Public Shares in favor of the extension proposal.
- Target is Envoy Medical, a medical device company with FDA Breakthrough Device Designation; no minimum cash condition.
- Extension increases likelihood of approval and may preserve trust account funds; no assurance of sufficient funds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000110465923024997/0001104659-23-024997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000110465923024997/tm237723d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-024997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer